Janux Therapeutics (JANX) Asset Utilization Ratio (2021 - 2026)

Janux Therapeutics (JANX) has 6 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.01, up 53.08% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01 (up 53.08% YoY), and the FY2025 annual result was 0.01, down 33.99% from the prior year.
• Asset Utilization Ratio advanced to 0.01 in Q1 2026 per JANX's latest filing, from 0.01 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.03 in Q1 2023 and troughed at 0.0 in Q2 2025.
• A 5-year average of 0.02 and a median of 0.02 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio surged 278.17% in 2022, then tumbled 98.08% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.02 in 2022, then slipped by 9.51% to 0.02 in 2023, then tumbled by 42.78% to 0.01 in 2024, then slipped by 18.13% to 0.01 in 2025, then jumped by 37.1% to 0.01 in 2026.
• Business Quant data shows JANX's Asset Utilization Ratio at 0.01 in Q1 2026, 0.01 in Q4 2025, and 0.01 in Q3 2025.